Does CANDESARTAN CILEXETIL Cause Malignant neoplasm progression? 21 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Malignant neoplasm progression have been filed in association with CANDESARTAN CILEXETIL (Candesartan). This represents 0.4% of all adverse event reports for CANDESARTAN CILEXETIL.
21
Reports of Malignant neoplasm progression with CANDESARTAN CILEXETIL
0.4%
of all CANDESARTAN CILEXETIL reports
8
Deaths
11
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CANDESARTAN CILEXETIL?
Of the 21 reports, 8 (38.1%) resulted in death, 11 (52.4%) required hospitalization, and 2 (9.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN CILEXETIL. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN CILEXETIL Cause?
Headache (706)
Fatigue (705)
Dyspnoea (673)
Drug ineffective (605)
Nausea (605)
Off label use (576)
Acute kidney injury (572)
Dizziness (528)
Malaise (518)
Pain (517)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CANDESARTAN CILEXETIL Alternatives Have Lower Malignant neoplasm progression Risk?
CANDESARTAN CILEXETIL vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN CILEXETIL vs CANGRELOR
CANDESARTAN CILEXETIL vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN CILEXETIL vs CANNABIDIOL
CANDESARTAN CILEXETIL vs CANNABIDIOL\HERBALS